OR2C1 inhibitors represent a class of chemicals that target the olfactory receptor 2C1 (OR2C1), a member of the G protein-coupled receptor (GPCR) superfamily. GPCRs are essential for a variety of physiological processes, with olfactory receptors (ORs) specifically involved in detecting odor molecules and transmitting signals through the olfactory system. OR2C1, being a highly specialized olfactory receptor, plays a role in sensing specific odorants or volatile compounds. Inhibitors of OR2C1 are designed to interfere with the receptor's ability to bind to or detect its corresponding odorant molecules, essentially blocking or modulating the receptor's signal transduction pathway. This inhibition can be achieved through direct interactions with the active site of the receptor or through allosteric modulation, altering the receptor's structural conformation and thereby impeding its normal function.
The molecular design of OR2C1 inhibitors typically involves a focus on structure-activity relationships (SARs) to identify compounds that exhibit selective affinity toward the OR2C1 receptor while minimizing interactions with other members of the GPCR family. These inhibitors can vary in complexity, ranging from small organic molecules to more intricate synthetic derivatives, all designed to interact specifically with the unique binding pocket of OR2C1. By blocking the receptor, researchers can study the olfactory pathways with more precision, shedding light on the structural and chemical properties that govern olfactory signaling. Additionally, the study of OR2C1 inhibitors provides insights into the molecular mechanisms of odor perception, offering a deeper understanding of how olfactory receptors like OR2C1 function in detecting chemical stimuli at the molecular level.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Disrupts protein transport by inhibiting the exchange of protein ARF, which can affect GPCR trafficking to the membrane, including OR2C1. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $451.00 | 3 | |
Inactivates G(i/o) proteins preventing their interaction with GPCRs, which can disrupt OR2C1 signaling. | ||||||
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
A non-selective beta-adrenergic receptor antagonist, which may alter GPCR signaling pathways and indirectly affect OR2C1. | ||||||
Carvedilol | 72956-09-3 | sc-200157 sc-200157A sc-200157B sc-200157C sc-200157D | 100 mg 1 g 10 g 25 g 100 g | $124.00 $240.00 $530.00 $999.00 $1530.00 | 2 | |
A beta-blocker and alpha-1 blocker, which can modulate GPCR signaling, potentially influencing OR2C1 function. | ||||||
Clozapine | 5786-21-0 | sc-200402 sc-200402A sc-200402B sc-200402C | 50 mg 500 mg 5 g 10 g | $69.00 $364.00 $2500.00 $4100.00 | 11 | |
An antipsychotic known to bind to various GPCRs, which can change the GPCR signaling landscape, potentially affecting OR2C1. | ||||||
Haloperidol | 52-86-8 | sc-507512 | 5 g | $190.00 | ||
A dopamine receptor antagonist, which can influence GPCR-mediated signaling, potentially affecting OR2C1. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Histone deacetylase inhibitor, which can affect gene expression and potentially alter the expression of GPCRs like OR2C1. | ||||||
Ketoconazole | 65277-42-1 | sc-200496 sc-200496A | 50 mg 500 mg | $63.00 $265.00 | 21 | |
Antifungal that can inhibit cytochrome P450 enzymes, potentially affecting the metabolism of GPCR signaling molecules, thus influencing OR2C1. | ||||||